skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Serum markers for type II diabetes mellitus

Patent ·
OSTI ID:1127136
; ; ; ; ;

A method for identifying persons with increased risk of developing type 2 diabetes mellitus utilizing selected biomarkers described hereafter either alone or in combination. The present invention allows for broad based, reliable, screening of large population bases and provides other advantages, including the formulation of effective strategies for characterizing, archiving, and contrasting data from multiple sample types under varying conditions.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RLO1830
Assignee:
Battelle Memorial Institute (Richland, WA)
Patent Number(s):
8,673,644
Application Number:
12/120,043
OSTI ID:
1127136
Country of Publication:
United States
Language:
English

References (5)

Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance patent-application June 2006
Complement C3 Precursor Biopolymer Markers Predictive of Type II Diabetes patent-application July 2006
Markers associated with arteriovascular events and methods of use thereof patent-application March 2008
Assay for Diabetes patent-application August 2008
Application of Proteomics in the Discovery of Candidate Protein Biomarkers in a Diabetes Autoantibody Standardization Program Sample Subset journal February 2008

Similar Records

Peptide and protein biomarkers for type 1 diabetes mellitus
Patent · Tue Aug 30 00:00:00 EDT 2016 · OSTI ID:1127136
Peptide and protein biomarkers for type 1 diabetes mellitus
Patent · Tue Jun 10 00:00:00 EDT 2014 · OSTI ID:1127136
Method for identifying type I diabetes mellitus in humans
Patent · Tue Apr 12 00:00:00 EDT 2011 · OSTI ID:1127136
+1 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES